Company research / CCCC
C4 Therapeutics, Inc. (CCCC)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, C4 Therapeutics, Inc. reported revenue of $35.95M. Revenue grew 1.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $35.04M.
Key ratios (year ended 2025-12-31)
-320.5%
Operating margin
-292.1%
Net margin
-40.9%
Return on year-end equity
1.0%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.